glp 1 loss of muscle mass Weight with GLP-1 medicines does not result in a disproportionate loss or function in obese mice and humans Strategies to prevent loss of

This substantial sample size provides robust statistical power and enhances the generalizability of our findings across key subgroups, such as patients with T2D, heart failure, or CKD - common indications for both GLP-1RA and SGLT2i

Systemic anti-aging (CJC-1295/Ipamorelin, Epithalon) Harder to photograph but improvements are real: Better sleep quality (week 2-4) Improved energy and recovery (week 4-8) Skin improvements (month 3-6) Better overall vitality Reduced biological aging markers (requires bloodwork to confirm) Photos show: More vibrant appearance

All of this comes in a tangy citrus vanilla flavored supplement, meant to be taken before meals on an empty stomach

Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP

Schooling CM, Lopez P, Yang Z, Zhao JV, Au Yeung SL, Huang JV

The primary actions are to regulate insulin and glucagon secretion only when plasma glucose exceeds normal fasting levels